604 related articles for article (PubMed ID: 34201214)
1. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
2. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
[TBL] [Abstract][Full Text] [Related]
3. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
[TBL] [Abstract][Full Text] [Related]
4. Tumor markers as an entry for SARS-CoV-2 infection?
Xia P; Dubrovska A
FEBS J; 2020 Sep; 287(17):3677-3680. PubMed ID: 32738184
[TBL] [Abstract][Full Text] [Related]
5. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.
Geng J; Chen L; Yuan Y; Wang K; Wang Y; Qin C; Wu G; Chen R; Zhang Z; Wei D; Du P; Zhang J; Lin P; Zhang K; Deng Y; Xu K; Liu J; Sun X; Guo T; Yang X; Wu J; Jiang J; Li L; Zhang K; Wang Z; Zhang J; Yan Q; Zhu H; Zheng Z; Miao J; Fu X; Yang F; Chen X; Tang H; Zhang Y; Shi Y; Zhu Y; Pei Z; Huo F; Liang X; Wang Y; Wang Q; Xie W; Li Y; Shi M; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2021 Sep; 6(1):347. PubMed ID: 34564690
[TBL] [Abstract][Full Text] [Related]
6. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
Guney C; Akar F
J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315
[TBL] [Abstract][Full Text] [Related]
7. Role of host factors in SARS-CoV-2 entry.
Evans JP; Liu SL
J Biol Chem; 2021 Jul; 297(1):100847. PubMed ID: 34058196
[TBL] [Abstract][Full Text] [Related]
8. The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues.
Qiao J; Li W; Bao J; Peng Q; Wen D; Wang J; Sun B
Biochem Biophys Res Commun; 2020 Dec; 533(4):867-871. PubMed ID: 33008593
[TBL] [Abstract][Full Text] [Related]
9. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
[TBL] [Abstract][Full Text] [Related]
11. The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.
Avolio E; Carrabba M; Milligan R; Kavanagh Williamson M; Beltrami AP; Gupta K; Elvers KT; Gamez M; Foster RR; Gillespie K; Hamilton F; Arnold D; Berger I; Davidson AD; Hill D; Caputo M; Madeddu P
Clin Sci (Lond); 2021 Dec; 135(24):2667-2689. PubMed ID: 34807265
[TBL] [Abstract][Full Text] [Related]
12. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS
J Biol Chem; 2021; 296():100759. PubMed ID: 33965375
[TBL] [Abstract][Full Text] [Related]
13. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
Wei C; Wan L; Yan Q; Wang X; Zhang J; Yang X; Zhang Y; Fan C; Li D; Deng Y; Sun J; Gong J; Yang X; Wang Y; Wang X; Li J; Yang H; Li H; Zhang Z; Wang R; Du P; Zong Y; Yin F; Zhang W; Wang N; Peng Y; Lin H; Feng J; Qin C; Chen W; Gao Q; Zhang R; Cao Y; Zhong H
Nat Metab; 2020 Dec; 2(12):1391-1400. PubMed ID: 33244168
[TBL] [Abstract][Full Text] [Related]
14. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
[TBL] [Abstract][Full Text] [Related]
15. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement.
Ulrich H; Pillat MM
Stem Cell Rev Rep; 2020 Jun; 16(3):434-440. PubMed ID: 32307653
[TBL] [Abstract][Full Text] [Related]
16. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.
Shilts J; Crozier TWM; Greenwood EJD; Lehner PJ; Wright GJ
Sci Rep; 2021 Jan; 11(1):413. PubMed ID: 33432067
[TBL] [Abstract][Full Text] [Related]
17. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN
Cells; 2021 Jun; 10(6):. PubMed ID: 34200372
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis.
Bayati A; Kumar R; Francis V; McPherson PS
J Biol Chem; 2021; 296():100306. PubMed ID: 33476648
[TBL] [Abstract][Full Text] [Related]
19. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2-Induced Inflammation.
Yang F; Liu C; Li P; Wu A; Ma-Lauer Y; Zhang H; Su Z; Lu W; von Brunn A; Zhu D
Mol Pharmacol; 2023 Dec; 104(6):239-254. PubMed ID: 37827578
[TBL] [Abstract][Full Text] [Related]
20. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.
Amendola A; Garoffolo G; Songia P; Nardacci R; Ferrari S; Bernava G; Canzano P; Myasoedova V; Colavita F; Castilletti C; Sberna G; Capobianchi MR; Piacentini M; Agrifoglio M; Colombo GI; Poggio P; Pesce M
Cardiovasc Res; 2021 May; 117(6):1557-1566. PubMed ID: 33705542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]